Terazosin Capsule
Product Images NDC 63629-2439

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 63629-2439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292439)

Terazosin Capsules, USP is a prescription medicine that comes in a container of 100 capsules. Each capsule contains 10 mg of Terazosin Hydrochloride, USP. This medicine is used to treat high blood pressure and an enlarged prostate. Be sure to store these capsules in a cool, dry place, away from children. It is recommended to be kept in a light-resistant container with a child-resistant closure. The NDC number for Terazosin Capsules, USP is 63629-2439-1.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

This text provides a graph or chart that shows the mean change from baseline over a period of 30 months. The time period is broken down into increments of 3 months with data points at Month 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, 27 and 30.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.